540 Chemie und zugeordnete Wissenschaften
Refine
Has Fulltext
- yes (20)
Is part of the Bibliography
- yes (20)
Year of publication
- 2017 (20) (remove)
Document Type
- Doctoral Thesis (16)
- Journal article (4)
Keywords
- Exziton (3)
- chemistry (3)
- Exzitonenkopplung (2)
- Ligand <Biochemie> (2)
- Merocyanine (2)
- Pharmakokinetik (2)
- ABC-Transporter (1)
- Aggregat <Chemie> (1)
- Arzneistofftransporter (1)
- Benchmark (1)
Institute
- Institut für Pharmazie und Lebensmittelchemie (8)
- Institut für Physikalische und Theoretische Chemie (5)
- Institut für Organische Chemie (3)
- Institut für Anorganische Chemie (2)
- Institut für Funktionsmaterialien und Biofabrikation (2)
- Abteilung für Funktionswerkstoffe der Medizin und der Zahnheilkunde (1)
- Fakultät für Physik und Astronomie (1)
- Institut für Pharmakologie und Toxikologie (1)
- Lehrstuhl für Tissue Engineering und Regenerative Medizin (1)
- Physikalisches Institut (1)
Sonstige beteiligte Institutionen
EU-Project number / Contract (GA) number
- 614623 (1)
In the present report, well-defined WO3 nanorods (NRs) and a rGO–WO\(_3\) composite were successfully synthesized using a one-pot hydrothermal method. The crystal phase, structural morphology, shape, and size of the as-synthesized samples were studied using X-ray diffraction (XRD) and transmission electron microscopy (TEM) measurements. The optical properties of the synthesized samples were investigated by Raman, ultraviolet-visible (UV-Vis) and photoluminescence (PL) spectroscopy. Raman spectroscopy and TEM results validate the formation of WO\(_3\) (NRs) on the rGO sheet. The value of the dielectric constant (ε′) of WO3 NRs and rGO–WO\(_3\) composite is decreased with an increase in frequency. At low frequency (2.5 to 3.5 Hz), the value of ε′ for the rGO–WO3 composite is greater than that of pure WO\(_3\) NRs. This could be due to the fact that the induced charges follow the ac signal. However, at higher frequency (3.4 to 6.0), the value of ε′ for the rGO–WO\(_3\) composite is less compared to that of the pure WO3 NRs. The overall decrease in the value of ε′ could be due to the occurrence of a polarization process at the interface of the rGO sheet and WO3 NRs. Enhanced interfacial polarization in the rGO–WO\(_3\) composite is observed, which may be attributed to the presence of polar functional groups on the rGO sheet. These functional groups trap charge carriers at the interface, resulting in an enhancement of the interfacial polarization. The value of the dielectric modulus is also calculated to further confirm this enhancement. The values of the ac conductivity of the WO\(_3\) NRs and rGO–WO\(_3\) composite were calculated as a function of the frequency. The greater value of the ac conductivity in the rGO–WO\(_3\) composite compared to that of the WO\(_3\) NRs confirms the restoration of the sp:\(^{++}\) network during the in situ synthesis of the rGO–WO\(_3\) composite, which is well supported by the results obtained by Raman spectroscopy.
Radiationless energy transfer is at the core of diverse phenomena, such as light harvesting in photosynthesis\(^1\), energy-transfer-based microspectroscopies\(^2\), nanoscale quantum entanglement\(^3\) and photonic-mode hybridization\(^4\). Typically, the transfer is efficient only for separations that are much shorter than the diffraction limit. This hampers its application in optical communication and quantum information processing, which require spatially selective addressing. Here, we demonstrate highly efficient radiationless coherent energy transfer over a distance of twice the excitation wavelength by combining localized and delocalized\(^5\) plasmonic modes. Analogous to the Tavis-Cummings model, two whispering-gallery-mode antennas\(^6\) placed in the foci of an elliptical plasmonic cavity\(^7\) fabricated from single-crystal gold plates act as a pair of oscillators coupled to a common cavity mode. Time-resolved two-photon photoemission electron microscopy (TR 2P-PEEM) reveals an ultrafast long-range periodic energy transfer in accordance with the simulations. Our observations open perspectives for the optimization and tailoring of mesoscopic energy transfer and long-range quantum emitter coupling.
[60]Fullerene hexakisadducts possessing 12 carboxylic acid side chains form crystalline hydrogen-bonding frameworks in the solid state. Depending on the length of the linker between the reactive sites and the malonate units, the distance of the [60]fullerene nodes and thereby the spacing of the frameworks can be controlled and for the most elongated derivative, continuous channels are obtained within the structure. Stability, structural integrity and porosity of the material were investigated by powder X-ray diffraction, thermogravimetry and sorption measurements.
New multifunctional nanoparticles (NPs) that can be used as contrast agents (CA) in different imaging techniques, such as photoluminescence (PL) microscopy and magnetic resonance imaging (MRI), open new possibilities for medical imaging, e.g., in the fields of diagnostics or tissue characterization in regenerative medicine. The focus of this study is on the synthesis and characterization of CaF\(_{2}\):(Tb\(^{3+}\),Gd\(^{3+}\)) NPs. Fabricated in a wet-chemical procedure, the spherical NPs with a diameter of 5–10 nm show a crystalline structure. Simultaneous doping of the NPs with different lanthanide ions, leading to paramagnetism and fluorescence, makes them suitable for MR and PL imaging. Owing to the Gd\(^{3+}\) ions on the surface, the NPs reduce the MR T\(_{1}\) relaxation time constant as a function of their concentration. Thus, the NPs can be used as a MRI CA with a mean relaxivity of about r = 0.471 mL·mg\(^{−1}\)·s\(^{−1}\). Repeated MRI examinations of four different batches prove the reproducibility of the NP synthesis and determine the long-term stability of the CAs. No cytotoxicity of NP concentrations between 0.5 and 1 mg·mL\(^{−1}\) was observed after exposure to human dermal fibroblasts over 24 h. Overall this study shows, that the CaF\(_{2}\):(Tb\(^{3+}\),Gd\(^{3+}\)) NPs are suitable for medical imaging.
The aim of the present work was to determine the breast adipose tissue composition regarding fatty acids, cholesterol and (aut)oxidation products of cholesterol in women without breast cancer and to identify associated variables. Thus the necessary methods were optimized and validated where required and the breast adipose tissues of women without breast cancer were collected and analyzed.
The gas chromatography with flame ionization detection was optimized for detection and separation of 37 relevant fatty acids. Fifty breast adipose tissues were analyzed using the optimized method. 26 fatty acids were detected in breast adipose tissues. The median proportion of saturated (sum of 11 fatty acids), monounsaturated (sum of 5 fatty acids), polyunsaturated (sum of 9 fatty acids) and one trans fatty acid were 34.6%, 53.2%, 12.1% and 0.3% respectively. Moreover, absolute levels of pentadecanoic acid (median: 0.37 mg/g, range: 0.08 - 1.31 mg/g), elaidic acid (median: 0.50 mg/g, range: 0.09 - 1.92 mg/g), linolenic acid (median: 0.88 mg/g, range: 0.10 - 3.06 mg/g) and docosahexaenoic acid (median: 0.31 mg/g, range: 0.04 - 1.80 mg/g) were determined in breast adipose tissues for the first time. These four fatty acids are indicative for consumption of dairy products, processed fats, vegetable oils such as flax seed oil and fish respectively.
Furthermore, for the investigation of cholesterol in breast adipose tissues a gas chromatography was optimized and validated. The accuracies of the method in three independent spiked samples with low, medium and high levels of cholesterol were 99.1 ± 10.1%, 87.0 ± 11.2%, and 103.4 ± 4.6% with precisions of 2.1, 2.1, and 0.8% respectively. Using external calibration with internal standard cholesterol was quantified in samples (median: 1.1 mg/g, range: 0.7 - 1.5 mg/g).
In order to detect (aut)oxidation products of cholesterol, gas chromatography coupled triple quadrupole mass spectrometry was optimized and validated. The accuracy was between 81.6% and 115.7% and precisions for low, medium and high oxy-cholesterols levels were below 10.0%. The quantitative determination of (aut)oxidation products of cholesterol was established using external calibration with an internal standard. The most abundant oxy-cholesterol was 5,6β-Epoxy- (median: 147.2 ng/g, range: 25.7 – 624.2 ng/g), followed by 5,6α-Epoxy- (median: 34.6 ng/g, range: 9.9 – 124.7 ng/g), 7-Keto- (median: 19.1 ng/g, range: 7.9 – 220.6 ng/g), 7α-Hydroxy- (median: 10.2 ng/g, range: 3.8 – 111.3 ng/g) and 7β-Hydroxy-Cholesterol (median: 3.5 ng/g, range: 1.0 – 45.6 ng/g) respectively. Median oxy-cholesterol/cholesterol ratios ranged from 0.0001 (5,6β-Epoxy-Cholesterol) to 0.000003 (7β-Hydroxy-Cholesterol).
Finally the associations between fatty acids, cholesterol and oxy-cholesterol were investigated using Spearman’s rank correlation. Absolute levels of elaidic acid were positively correlated with levels of linolenic and docosahexaenoic acid (R = 0.79, 0.68, p < 0.01). Absolute levels of linolenic acid were positively associated with levels of docosahexaenoic acid (R = 0.81, p < 0.01). Moreover, relative proportions of saturated fatty acids capric, myristic, palmitic and stearic acid were negatively correlated with oleic acid (R = -0.36, -0.71, -0.65, -0.39, p < 0.05). Tissue levels of cholesterol were not correlated with levels of 5,6α/β-Epoxy-Cholesterols but were negatively associated with that of 7α-Hydroxy-, 7β-Hydroxy- and 7-Keto-Cholesterol (R = -0.29, -0.32, -0.29 p = 0.04, 0.02, 0.04). Levels of 7-Keto- and 7-Hydoxy-Cholesterol were strongly correlated with each other (R = 0.81, 0.91, p < 0.01) and, weaker, with 5,6α/β-Epoxy-Cholesterols (R = 0.60-0.70, p < 0.01). 5,6α/β-Epoxy-Cholesterols were associated positively with each other (R = 0.90, P < 0.01). Total oxy-cholesterol, 7β-Hydroxy-Cholesterol, and 5,6β-Epoxy-Cholesterol levels were correlated with relative proportions of elaidic acid (R = 0.30, 0.30, and 0.31 respectively, p = 0.04, 0.03, 0.03, respectively), whereas no correlation was observed between levels of oxy-cholesterols and relative proportion of pentadecanoic acid, linolenic acid and docosahexaenoic acid.
Furthermore, Spearman’s rank correlation was performed to investigate the relationship of fatty acids, cholesterol and oxy-cholesterol with age and body mass index. The relative proportions of total saturated fatty acids were negatively correlated with age (R = -0.47, p < 0.01) and body mass index (R = -0.29, p = 0.05). A positive significant correlation was observed between proportions of oleic acid and body mass index (R = 0.32, p = 0.02). There was no correlation between levels of cholesterol and body mass index or age. Likewise, no correlations of oxy-cholesterol levels with age or body mass index were observed.
In sum, in this work the quantification methods of cholesterol and oxy-cholesterol were validated. The validation data met the criteria according to the FDA guideline. Using the validated methods the absolute levels of cholesterol and oxy-cholesterols were determined in breast adipose tissue of human females for the first time.
Describing the light-to-energy conversion in OSCs requires a multiscale understanding of the involved optoelectronic processes, i.e., an understanding from the molecular, intermolecular, and aggregate perspective. This thesis presents such a multiscale description to provide insight into the processes in the vicinity of the organic::organic interface, which are crucial for the overall performance of OSCs. Light absorption, exciton diffusion, photoinduced charge transfer at the donor-acceptor interface, and charge separation are included. In order to establish structure-property relationships, a variety of different molecular p-type semiconductors are combined at the organic donor-acceptor heterojunction with fullerene C60, one of the most common acceptors in OSCs. Starting with a comprehensive analysis of the accuracy of diverse ab initio, DFT, and semiempiric methods for the properties of the individual molecules, the intermolecular, and aggregate/device stage are subsequently addressed. At all stages, both methodological concepts and physical aspects in OSCs are discussed to extend the microscopic understanding of the charge generation processes.
Calcium phosphate biocements are inherently brittle materials due to their ceramic nature. Hence, currently applied cement formulations are only indicated for non-load bearing application sites. An approach to reduce cement brittleness is based on the use of cement – polymer composites, which combine the flexibility of a polymeric phase with the hardness and compression strength of a cement matrix. Here, a relatively new strategy is the use of “dual-setting” cements, in which the polymeric phase is simultaneously build up from monomers or prepolymers during cement setting. This approach largely maintains basic properties of the fresh paste such as rheology or setting time. Previous works on such dual setting cements were dealing with a radical polymerization reaction to create the polymeric network. This type of reaction requires the addition of a suitable initiator system (e.g. a tertiary amine in conjunction with ammonium peroxosulfate), which are often cytotoxic and may interfere with the cement setting conditions. The current thesis dealt with alternative strategies, in which the cross-linking and gelation of the second (polymeric or inorganic) cement phase is initiated by the chemical conditions of the setting reaction such that no additional initiator has to be added to the cement paste.
In a first approach a six armed star molecule functionalized with isocyanate groups as reactive termini (NCO–sP(EO-stat-PO)) was used to build up a hydrogel matrix, which was then subsequently mineralized with hydroxyapatite nanocrystals following the hydrolysis of incorporated -tricalcium phosphate particles. The stimulus to initiate hydrogel cross-linking are water molecules, which subsequently hydrolyzed isocyanate groups to amines, which then cross-linked with unreacted isocyanate to form urea-bonds. Here, it was possible to show the advantages features of a dual setting system in comparison to the simple combination of hydrogels with unreactive filler particles. By the formation of the cement matrix within the hydrogel a strength improvement by the factor of 30 could be observed. Furthermore, by applying a dual setting system higher mineral concentrations are realizable. The mechanical properties such as elasticity, compression strength and E-modulus of a composite with 30 wt% NCO–sP(EO-stat-PO) were found to be similar to the properties of cancellous bone.
With the motivation to develop a dual setting and resorbable cement, a brushite (CaHPO4·2H2O) forming cement was modified with a second inorganic silica based precursor. The latter was obtained by pre-hydrolysing tetraethyl orthosilicate (TEOS) under acidic conditions. This silica precursor was mixed with a cement powder composed of ß-tricalcium phosphate and monocalcium phosphate, whereas cement setting occurred by a dissolution–precipitation process to form a matrix of brushite. Simultaneously, the increase of the pH during setting from initially 1-2 to values > 4 initiated the condensation reaction of the hydrolysed TEOS. This resulted in an interpenetrating phase composite material in which the micropores of the cement were filled with the nanoporous silica gel. This resulted in a higher density and a compressive strength of 24 MPa, which is approximately 5-10 times higher than the CPC reference at the same powder to liquid ratio. The microporous character of the composites also altered the release of vancomycin as a model drug, whereby in contrast to the quantitative release from the CPC reference, approx. 25 % of the immobilised drug remained in the composite matrix. It was also observed, that a variation of the TEOS content in the composite enabled a control over cement phase composition to form either brushite, anhydrous monetite or a biphasic mixture of both. Cytocompatibility tests revealed that composites with the highest silicate content showed an increased cell proliferation compared to the silica-free brushite reference. Proliferation was found to be similar to a hydroxyapatite reference with a significant higher activity per cell. Mechanistically, the improved biological response could not be attributed to the released silicate ions, but to a decreased release of phosphate and adsorption of magnesium ions from the cell culture medium.
Finally, an investigated dual setting cement system was based on the combination of a brushite forming cement powder with an aqueous silk fibroin solution. Here, changes of both ion concentration and pH during cement setting were shown to build up an interpenetrating fibroin – brushite composite with combined properties of the elastic polymer and the rigid cement. Mechanistically, the low pH of the cement paste (2) as well as the free Ca2+ ions during setting resulted in a conformation change of the dissolved fibroin from random coil to ß-sheet structure. This leads to a rapid gelation and contraction of the fibroin phase with a self-densifying effect on the cement paste. The set composites showed typical ductile fracture behavior under dry testing conditions and a high elasticity under wet conditions with a mechanical strength nearly an order of magnitude higher than the fibroin free cement reference. Cell number and activity against MG63 cells were strongly increased on silk fibroin cement composite surfaces at later time points, which could be again attributed to a decreased ion release and adsorption compared to the fibroin free cements. This in turn slowed down the in vitro degradation of the CPC phase in such composites.
Drug delivery of therapeutic gases – strategies for controlled and local delivery of carbon monoxide
(2017)
The isoenzyme heme oxygenase 1 (HO-1) is a key element for maintaining cellular homeostasis. Upregulated in response to cellular stress, the HO-1 degrades heme into carbon monoxide (CO), biliverdin, and Fe2+. By means of a local cell-protective feedback loop the enzyme triggers numerous effects including anti-oxidative, anti-apoptotic, and anti-inflammatory events associated with complex signalling patterns which are largely orchestrated by CO. Various approaches to mimic this physiological HO-1 / CO system aiming for a treatment of medical conditions have been described [1]. These preclinical studies commonly applied CO systemically via (i) inhalation or (ii) using CO-Releasing Molecules (CORMs) [2]. The clinical use of these approaches, however, is challenged by a lack of practicability and substantial safety issues associated with the toxicity of high systemic doses of CO that are required for triggering therapeutic effects. Therefore, one rational of this thesis is to describe and evaluate strategies for the local delivery of CO aiming for safe and effective CO therapeutics of tomorrow.
Die Arbeit umfasst zum einen Untersuchungen zu hochhalogenierten 1-Aminocarba-closo-dodecaboraten, zum anderen Untersuchungen zu hochfluorierten Aminocarba-closo-dodecaboraten mit einer an ein Boratom gebundenen Amino-Funktion. Außerdem wurden im diesem Zuge closo-Undecaborat-Cluster untersucht, da diese als interessante Ausgangsverbindungen für funktionalisierte {CB11}-Derivate eingesetzt werden können.
Successful formulation development of novel, particularly organic APIs of low molecular weight as candidates for ground-breaking pharmaceutical products is a major challenge for the pharmaceutical industry because of the poor aqueous solubility of most of these compounds.
The hit identification strategies of drug development in use today apply high throughput screening techniques for the investigation of thousands of substances. This approach led to a systematical increase in molecular weight and lipophilicity and a decrease of water solubility of lead compounds reaching market access.
The high lipophilicity causes an excellent permeability of the compounds which favours the absorption process from the small intestine, but it causes a decrease of water-solubility. It becomes evident that an adequate aqueous solubility is necessary for absorption of the API from the gastrointestinal fluids into the systemic circulation and hence for efficacy of the pharmaceutical product. Only an dissolved API is getting absorbed and becomes efficacious. The precipitated proportion is resigned directly. Therefore, the development of an individual formulation aligning the physicochemical characteristics is necessary for every API to produce supersaturated solutions in the small intestine and to reach an adequate bioavailability after absorption into the systemic circulation.
In this thesis a specific formulation development was investigated for two exemplary poorly water-soluble APIs to replace the empirical approach often used today. The basic tyrosine-kinase inhibitor imatinib and six different acetylated amino acids were transferred into ILs. As compared to the free base and the mesylate salt, which is marketed by Novartis AG as Gleevec®, the dissolution rate as well as the supersaturation time was increased significantly. By changing the mesylate anion with its potential genotoxic risks, the total toxicity of the drug product could be decreased. The amorphous ILs proved adequate stability under forcing conditions and there was no recrystallization of the free base observed. The amorphous character of the ILs caused an increased amount of water vapour sorption which can be compensated by special packaging materials. Taken together, the presentation of imatinib as an IL is intended for oral administration as a tablet and can cause a reduction of dose because of the increased solubility. Therefore, the occurrence of side effects can be reduced as compared to Gleevec®. If there is actually an increased bioavailability to observe, has to be proved by the execution of animal trials.
The novel NOX inhibitor VAS3947 is intended for the treatment of endothelial dysfunctions causing diseases like heart failure and stroke. The compounds poor aqueous solubility hindered further clinical development so far and make the drug candidate to remain in a very early stage of the drug development process. Therefore, different formulation concepts were evaluated in this study:
An amorphous solid dispersion prepared from VAS3947 and Eudragit® L100 by means of spray drying was able to increase the dissolution rate and solubility of the compound significantly, but with the accomplished kinetic solubility being in the low µM range it is not possible to reach therapeutic plasma concentrations.
In contrast, the incorporation into cyclodextrins resulted in an 760-fold increased solubility. Different cyclodextrins were evaluated. Especially the lipophilic derivatives of the β-cyclodextrin showed to be the most adequate excipients. The incorporation of the API into the cyclodextrin cavity was proved by means of NMR spectroscopy. Additionally, a formulation of VAS3947 and hydroxypropyl-β-cyclodextrin was prepared. This formulation is intended for the intravenous application during animal trials, which have to be conducted to get to know the pharmacokinetics of VAS3947. This formulation reached a concentration of 1 mg/mL spending striking protection of VAS3947 against degradation.
Presentation of VAS3947 as a microemulsion system led also to increase the aqueous solubility of the compound, but not in the same extent as the cyclodextrin formulation. Beside the formulation development a physicochemical characterization was performed to get to know important parameters such as log P and pKa values of VAS3947. An HPLC method was developed and validated to analyse the extent of solubility improvement.
A major issue of the compound VAS3947 and all related triazolopyrimidine derivatives, developed by Vasopharm GmbH, is the insufficient chemical stability because of presence of a hemiaminal moiety in the chemical structure. Stability investigations and an extensive biopharmaceutical characterization confirm the hindering of further clinical development by insufficient drug stability and high cytotoxicity. Poor aqueous solubility is an additional disadvantage which can be handled by a concerted formulation development.